1. Introduction
1.1. Market Scope and Segmental Definition
1.2. Assumptions & Limitation
2. Research Methodology
2.1. Research Approach & Data Sources
2.2. Forecasting Model
3. Executive Summary
3.1. Analyst?s Insights
3.2. Top Line Market estimation
3.3. Value Chain Analysis
4. Market Forces
4.1. Key Industry Drivers, Restraints and Opportunities
4.2. Industry Trends
5. Market Outlook by Service Type (Current size & future market estimates)
5.1. Bioanalysis and DMPK studies
5.2. Toxicity studies
5.3. Other preclinical services
6. Market Outlook by End user (Current size & future market estimates)
6.1. Biopharmaceutical companies
6.2. Government bodies and Academic institutes
6.3. Others
7. Market Outlook by Regions (Current size & future market estimates)
7.1. North America
7.1.1. U.S.
7.1.2. Canada
7.2. Europe
7.2.1. U.K.
7.2.2. Germany
7.3. APAC
7.3.1. Japan
7.3.2. China
7.4. Latin America
7.4.1. Brazil
7.4.2. Mexico
7.5. MEA
7.5.1. South Africa
8. Competitive Landscape
8.1. Market Share/Market Ranking Analysis
8.2. Competitive Market Scenario (New Product Innovations, Key Strategic Moves & Partnerships, Start-ups Ecosystem)
9. Company Profiles
Includes: Company Overview, Product & Services Offerings, Financials (only for listed companies), New Developments and Innovation)
9.1. Envigo
9.2. MPI Research
9.3. Eurofins Scientific
9.4. PRA Health Sciences, Inc.
9.5. WuXi AppTec
9.6. Medpace
9.7. Pharmaceutical Product Development (PPD), LLC
9.8. PARAXEL International Corporation
9.9. Charles River
9.10. ICON plc.
9.11. Laboratory Corporation of America Holdings